Fundraising Fox

Venus Concept

Toronto, US · Founded 2009 · Delaware corporation · 421 employees on LinkedIn · 5 known investors

Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies. It serves medical spas, dermatologists, plastic surgeons, and hair transplant physicians across more than 60 countries.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

Venus Concept was founded in 2009 by Domenic Serafino.

DS
Domenic SerafinoFounder
KG
Kirk GunhusExecutive
RPRoss Portaro
Ross PortaroExecutive
AGAnna Georgiadis
Anna GeorgiadisExecutive
MK
Melissa KangExecutive
MMMichael Mandarello
Michael MandarelloExecutive
DDDominic Della Penna
Dominic Della PennaExecutive
RDRajiv De Silva
Rajiv De SilvaChief Executive Officer and Director
JM
James McCollumDirector, President and Chief Executive Officer
WK
William KelleyNamed on SEC filing
BV
Boris VaynbergNamed on SEC filing
GV
Greg Van StaverenNamed on SEC filing

Investors · 5

APERTURE Venture PartnersBoston · $1M – $5M
Essex Woodlands Healthcare PartnersNew York · $20M – $80M
Longitude CapitalMenlo Park · $10M – $30Mvia Juliet Bakker · board
ClarusreportedCambridge
HealthQuest CapitalreportedRedwood City

Reported raises · per SEC filings

Form D private placements

$219.3M disclosed across 13 of 14 rounds · 2013–2026

▶$1.5MraisedApr 2026 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kirk GunhusExecutive Officer
  • Ross PortaroExecutive Officer
  • Anna GeorgiadisExecutive Officer
  • Melissa KangExecutive Officer
  • Michael MandarelloExecutive Officer
  • Avinash AminDirector
  • Dominic Della PennaExecutive Officer
  • Rajiv De SilvaExecutive Officer
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedMar 2024 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hemanth VargheseExecutive Officer
  • Anthony NataleDirector
  • Keith SullivanDirector
  • S. Tyler HollmigDirector
  • Rajiv De SilvaExecutive Officer, Director
  • Fritz LaPorteDirector
  • Domenic Della PennaExecutive Officer
  • Louise LacchinDirector
  • Scott BarryDirector
  • Garheng KongDirector
  • Michael MandarelloExecutive Officer
Offering amount
$1.1M
Amount sold
$1.1M
Sales commissions
$83.9K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2023 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Domenic Della PennaExecutive Officer
  • Richard Scott BarryDirector
  • Keith SullivanDirector
  • Stanley Tyler HollmigDirector
  • Hemanth VargheseExecutive Officer
  • Louise LacchinDirector
  • Anna GeorgiadisExecutive Officer
  • William McGrailExecutive Officer
  • Ross PortaroExecutive Officer
  • Garheng KongDirector
  • Fritz LaPorteDirector
  • Michael MandarelloExecutive Officer
  • Anthony NataleDirector
  • Rajiv De SilvaExecutive Officer, Director
Offering amount
$9M
Amount sold
$2M
Minimum investment
$500K
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.7MraisedNov 2022 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard Scott BarryDirector
  • Keith SullivanDirector
  • Michael MandarelloExecutive Officer
  • Louise LacchinDirector
  • Anna GeorgiadisExecutive Officer
  • Yoni IgerExecutive Officer
  • Fritz LaPorteDirector
  • Garheng KongDirector
  • William McGrailExecutive Officer
  • Rajiv De SilvaDirector, Executive Officer
  • Stanley Tyler HollmigDirector
  • Ross PortaroExecutive Officer
  • Domenic Della PennaExecutive Officer
  • Soren Maor SinayExecutive Officer
  • Anthony NataleDirector
  • Anat KotlerExecutive Officer
  • Hemanth VargheseExecutive Officer
Offering amount
$6.7M
Amount sold
$6.7M
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedDec 2021 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Louise LacchinDirector
  • Fritz LaPorteDirector
  • Domenic SerafinoExecutive Officer, Director
  • Keith SullivanDirector
  • Anthony NataleDirector
  • Garheng KongDirector
  • Scott BarryExecutive Officer, Director
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.3MraisedDec 2021 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Louise LacchinDirector
  • Scott BarryDirector
  • Domenic SerafinoExecutive Officer, Director
  • Fritz LaPorteDirector
  • Garheng KongDirector
  • Anthony NataleDirector
  • Keith SullivanDirector
Offering amount
$12.3M
Amount sold
$12.3M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.5MraisedNov 2019 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott BarryDirector
  • Soeren Maor SinayExecutive Officer
  • William KelleyExecutive Officer
  • Melissa KangExecutive Officer
  • Yoni IgerExecutive Officer
  • Anna GeorgiadisExecutive Officer
  • Domenic Di SistoExecutive Officer
  • Domenic Della PennaExecutive Officer
  • Frederic MollDirector
  • Keith SullivanDirector
  • Anthony NataleDirector
  • Fritz LaPorteDirector
  • Louise LacchinDirector
  • Garheng KongDirector
  • Boris VaynbergExecutive Officer
  • Juliet Tammenoms BakkerDirector
  • Domenic SerafinoExecutive Officer, Director
Offering amount
$50.5M
Amount sold
$50.5M
Sales commissions
$1.1M
Placement agents
Northland Securities, Inc., Oppenheimer & Co. Inc., Evercore Group L.L.C.
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.1MraisedAug 2019 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna GeorgiadisExecutive Officer
  • Domenic Della PennaExecutive Officer
  • Domenic SerafinoExecutive Officer, Director
  • Juliet BakkerDirector
  • Garheng KongDirector
  • Maor SinayExecutive Officer
  • Louise LacchinDirector
  • Fritz LaPorteDirector
  • Anthony NataleDirector
  • Boris VaynbergExecutive Officer
  • Domenic Di SistoExecutive Officer
  • Scott BarryDirector
  • Yoni IgerExecutive Officer
  • Melissa KangExecutive Officer
  • William KelleyExecutive Officer
Offering amount
$14.1M
Amount sold
$14.1M
First sale
Aug 2019
Incorporated
Corporation, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Real Self100 shared keywordsRealSelf is an online platform where consumers can research cosmetic and aesthetic procedures, read peer reviews with "Worth It" ratings, and view average cost information for treatments such as HydraFacial, PRP injections, and Sculptra. It serves people considering surgical and non-surgical skin rejuvenation and cosmetic treatments.

Companies competing with Venus Concept for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Madryn moves toward full control of Venus Concept | VERO SEC Filing - Form SCHEDULE 13D/Astocktitan.net · Mar 2026Venus Concept extends bridge loan maturity and receives $1.5 million funding By Investing.cominvesting.com · Dec 2025Venus Concept Raises a Total of Approximately $2.7 Million in Gross Proceeds from Previously Announced Registered Direct Offerings of Common Stockglobenewswire.com · Apr 2025Venus Concept secures additional $2M in funding By Investing.comng.investing.com · Apr 2025Venus Concept Closes $38m Equity Funding - FinSMEsfinsmes.com · Jul 2017Venus Concept Secures $10 Million in Funding - Longitude Capitallongitudecapital.com · May 2014

Frequently asked questions

What does Venus Concept do?
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies. It serves medical spas, dermatologists, plastic surgeons, and hair transplant physicians across more than 60 countries.
Who founded Venus Concept?
Venus Concept was founded by Domenic Serafino in 2009.
Who are Venus Concept's investors?
Venus Concept's investors include APERTURE Venture Partners, Essex Woodlands Healthcare Partners, Longitude Capital, Clarus, HealthQuest Capital.
How much funding has Venus Concept raised?
Venus Concept has disclosed $219.3M raised across 13 of its 14 known rounds.
Where is Venus Concept headquartered?
Venus Concept is headquartered in Toronto, US.